
We are a start-up committed to making precision medicine a living reality for the treatment for ADHD.
We use AI methods to map together elements, including clinical factors, genes and environment. We transform multi-dimensional data into prediction models of which treatment plan is likely to work best for each individual.
Are we there yet? Still at the stage of refining our prediction models, we are working closely with clinicians and individuals with lived experience. While in process, we have been actively involved in sharing the latest science and building awareness.
Core to everything we do is honest, interpretable AI and most importantly, the human connection!
AIMH in print
ADHD does occur across the lifespan.
Article published in the July 2025 newsletter of Unison News (p 6).
By Venture for Cananda (VFC) intrapreneur, Sebastian White.
Collaborative work together with Communications Director Mel Lefebvre, & CEO Sarojini Sengupta.
News18 article on ADHD & procrastination, by VFC intrapreneur Mujtaba Kureshi
Collaborative work together with Mel & Sarojini.
First Post article:
Unravelling the complexity of ADHD, by Mel & Sarojini.
News18 article on treatment options for ADHD.
News18 article on the risks of ADHD in women and girls.
First Post article to increase awareness of ADHD in India.
CADDRA ADHD Research Digest
Issue 5, March 2022. Click to read the article by CSO Tyler Bonnell & Sarojini. Visit here to watch the interview.
Sharing a glimpse of the entrepreneurial journey, together with other entrepreneurs.
Collaboration with IVADO.







